Covance

Covance, Sihuan partner in preclinical and clinical portfolio development

Thursday, April 2, 2015 12:56 PM

LabCorp, a North Carolina-based healthcare diagnostics company, and Shandong XuanZhu Pharma, the wholly-owned subsidiary for innovative drug R&D of Sihuan Pharmaceutical, have inked a long-term partnership with Covance Drug Development (part of LabCorp) to support the global development of Sihuan’s drug candidate pipeline.

More... »


Survey: PSI, INC Research, Chiltern rated top CROs by investigative sites

Wednesday, April 1, 2015 08:00 AM

More than 1,900 global investigative sites rate the best CROs for which to work in a new survey conducted by CenterWatch, a provider of global clinical trials information. The survey results were released in the April issue of The CenterWatch Monthly newsletter.

More... »


Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Monday, March 2, 2015 08:00 AM

Huntingdon Life Sciences, a British non-clinical CRO that acquired U.S. CRO Harlan Laboratories nine months ago, has launched a rebranding of the combined companies and has set its expansion sights on competing against early-phase giants Charles River Laboratories and Covance.

More... »

LabCorp completes acquisition of Covance

Monday, February 23, 2015 01:00 PM

Laboratory Corporation of America Holdings (LabCorp) has completed its acquisition of Covance, following its definitive purchase agreement Nov. 2, 2014.

More... »

PharmaTimes clinical research awards to be presented Feb. 26

Thursday, February 12, 2015 03:33 PM

The 2015’s PharmaTimes Clinical Researcher of the Year—The Americas awards will be presented Feb. 26 in North Carolina.

More... »

Covance launches new solution to bridge preclinical to clinical development

Monday, January 26, 2015 12:48 PM

Princeton, N.J.-based CRO Covance has introduced Covance Early Phase Development Solutions, a multi-disciplined approach to early drug development, partnership and continuity to generate greater value in asset development and achieve accelerated delivery timelines.

More... »

Covance to vote on proposed acquisition by LabCorp Feb. 18

Tuesday, January 13, 2015 08:00 AM

CRO Covance has set a date for a special meeting of its stockholders to consider and vote on the previously announced proposed acquisition of Covance by Laboratory Corporation of America Holdings (LabCorp) and certain other related matters. The special meeting will be held Feb. 18, at 8 a.m., in Princeton, N.J.

More... »

PRA Health Sciences becomes latest big CRO to launch IPO

Thursday, November 13, 2014 03:38 PM

PRA Health Sciences launched its initial public offering this morning, raising $306 million from the sale of nearly 17 million shares at $18 per share—below plans it announced in September to raise up to $375 million.

More... »

LabCorp to acquire Covance, creating giant one-stop shop for diagnostics, clinical research

Monday, November 3, 2014 12:57 PM

Laboratory Corp. of America Holdings (LabCorp), a large provider of medical testing services, has agreed to acquire CRO Covance in a $6.1 billion cash and stock deal to create a giant healthcare diagnostics company.      

More... »

Covance, Novartis collaborate to develop a clinical data warehouse

Wednesday, October 15, 2014 01:21 PM

Covance has entered an in-kind collaboration with Novartis Institutes for Biomedical Research (NIBR) to accelerate the development of a state-of-the-art clinical data warehouse designed to support data integration and meta-analysis for preclinical and clinical research.

More... »


CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs